Oruka Therapeutics, Stock Book Value Per Share
| ORKA Stock | 20.26 1.57 8.40% |
Oruka Therapeutics, fundamentals help investors to digest information that contributes to Oruka Therapeutics,'s financial success or failures. It also enables traders to predict the movement of Oruka Stock. The fundamental analysis module provides a way to measure Oruka Therapeutics,'s intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Oruka Therapeutics, stock.
Oruka |
Oruka Therapeutics, Company Book Value Per Share Analysis
Oruka Therapeutics,'s Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
More About Book Value Per Share | All Equity Analysis
Book Value per Share | = | Common EquityAverage Shares |
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.
| Competition |
In accordance with the recently published financial statements, the book value per share of Oruka Therapeutics, is about 0.0 times. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The book value per share for all United States stocks is 100.0% higher than that of the company.
Oruka Book Value Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Oruka Therapeutics,'s direct or indirect competition against its Book Value Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Oruka Therapeutics, could also be used in its relative valuation, which is a method of valuing Oruka Therapeutics, by comparing valuation metrics of similar companies.Oruka Therapeutics, is currently under evaluation in book value per share category among its peers.
Oruka Fundamentals
| Current Valuation | 899.11 M | ||||
| Shares Outstanding | 1000 K | ||||
| Number Of Shares Shorted | 656.34 K | ||||
| Target Price | 41.25 | ||||
| Market Capitalization | 888.26 M | ||||
| Annual Yield | 0.78 % |
About Oruka Therapeutics, Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Oruka Therapeutics,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Oruka Therapeutics, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Oruka Therapeutics, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Oruka Therapeutics, offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Oruka Therapeutics,'s financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Oruka Therapeutics, Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Oruka Therapeutics, Stock:Check out Oruka Therapeutics, Piotroski F Score and Oruka Therapeutics, Altman Z Score analysis. For information on how to trade Oruka Stock refer to our How to Trade Oruka Stock guide.You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Oruka Therapeutics,. If investors know Oruka will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Oruka Therapeutics, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Oruka Therapeutics, is measured differently than its book value, which is the value of Oruka that is recorded on the company's balance sheet. Investors also form their own opinion of Oruka Therapeutics,'s value that differs from its market value or its book value, called intrinsic value, which is Oruka Therapeutics,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Oruka Therapeutics,'s market value can be influenced by many factors that don't directly affect Oruka Therapeutics,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Oruka Therapeutics,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Oruka Therapeutics, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Oruka Therapeutics,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.